F. Heerinckx

Plasma and red blood cell membrane accretion and pharmacokinetics of RT001 (bis-allylic 11,11-D2-linoleic acid ethyl ester) during long term dosing in patients.

M. Shchepinov, J. Brenna, L. V. D. van der Ploeg, 2020, Journal of pharmaceutical sciences.

RT001 in Progressive Supranuclear Palsy—Clinical and In-Vitro Observations

M. Shchepinov, P. Angelova, P. Atwal, 2021, Antioxidants.

The infantile neuroaxonal dystrophy rating scale (INAD-RS)

D. Adams, P. Atwal, Darius J. Adams, 2020, Orphanet Journal of Rare Diseases.

Randomized, clinical trial of RT001: Early signals of efficacy in Friedreich's ataxia

M. Shchepinov, T. Zesiewicz, M. Kilpatrick, 2018, Movement disorders : official journal of the Movement Disorder Society.

Comparative Liquid Chromatographic Stability Study of Thymidine and 1- (2-Deoxy-α-D-Erythro-Pentofuranosyl) Thymine

E. Roets, J. Hoogmartens, P. Herdewijn, 1994 .

Treatment of infantile neuroaxonal dystrophy with RT001: A di‐deuterated ethyl ester of linoleic acid: Report of two cases

M. Shchepinov, D. Adams, P. Atwal, 2020, JIMD reports.

Double blind trial of a deuterated form of linoleic acid (RT001) in Friedreich ataxia

S. Subramony, S. Perlman, K. Mathews, 2022, Journal of Neurology.

Wearable body and wireless inertial sensors for machine learning classification of gait for people with Friedreich's ataxia

Robert LeMoyne, Harry J. Saal, Frederic Heerinckx, 2016, 2016 IEEE 13th International Conference on Wearable and Implantable Body Sensor Networks (BSN).